Sarah Ellen Braun1,2, Autumn Lanoye2,3, Farah J Aslanzadeh4, Ashlee R Loughan1,2. 1. Department of Neurology, Virginia Commonwealth University, Richmond, Virginia, USA. 2. Massey Cancer Center, Richmond, Virginia, USA. 3. Department of Health Behavior and Policy, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA. 4. Department of Psychology, Virginia Commonwealth University, Richmond, Virginia, USA.
Abstract
OBJECTIVE: We assessed agreement between patient- and informant-report on the Behavior Rating Inventory of Executive Function - Adult (BRIEF-A) in patients with primary brain tumors (PBT) and differences on BRIEF-A in neurocognitive (intact v. impaired), psychological (asymptomatic v. distressed), and functional (independent v. dependent) categories using both patient- and informant-report. METHOD: PBT patients (n = 102) completed neuropsychological evaluations including the BRIEF-A, clinical interview, neurocognitive tests, and mood questionnaires. Correlations between the BRIEF-A and Informant (n = 39) were conducted. Differences in patient and informant BRIEF-A indices were investigated across five classifications: neurocognitive functioning, psychological functioning, medication management, appointment management, and finance management. RESULTS: Patient and informant BRIEF were correlated. There was no difference on BRIEF-A or Informant indices for intact v. impaired neurocognitive status. Higher BRIEF-A and Informant indices were observed among psychologically distressed v. asymptomatic patients. Results showed higher BRIEF indices among those requiring assistance with medication, appointments, and finances. CONCLUSIONS: Patients and informants agreed in their reports of executive function (EF). These reports, while not different in neurocognitive classification, were different in psychological functioning and in those needing assistance with instrumental activities of daily living (IADL). Patient- and informant-reported EF may provide important data regarding psychological and IADL functioning in this population.
OBJECTIVE: We assessed agreement between patient- and informant-report on the Behavior Rating Inventory of Executive Function - Adult (BRIEF-A) in patients with primary brain tumors (PBT) and differences on BRIEF-A in neurocognitive (intact v. impaired), psychological (asymptomatic v. distressed), and functional (independent v. dependent) categories using both patient- and informant-report. METHOD: PBT patients (n = 102) completed neuropsychological evaluations including the BRIEF-A, clinical interview, neurocognitive tests, and mood questionnaires. Correlations between the BRIEF-A and Informant (n = 39) were conducted. Differences in patient and informant BRIEF-A indices were investigated across five classifications: neurocognitive functioning, psychological functioning, medication management, appointment management, and finance management. RESULTS: Patient and informant BRIEF were correlated. There was no difference on BRIEF-A or Informant indices for intact v. impaired neurocognitive status. Higher BRIEF-A and Informant indices were observed among psychologically distressed v. asymptomatic patients. Results showed higher BRIEF indices among those requiring assistance with medication, appointments, and finances. CONCLUSIONS: Patients and informants agreed in their reports of executive function (EF). These reports, while not different in neurocognitive classification, were different in psychological functioning and in those needing assistance with instrumental activities of daily living (IADL). Patient- and informant-reported EF may provide important data regarding psychological and IADL functioning in this population.
Authors: Kevin Duff; Mike R Schoenberg; Doyle Patton; James Mold; James G Scott; Russell L Adams Journal: J Int Neuropsychol Soc Date: 2004-10 Impact factor: 2.892
Authors: Terri S Armstrong; Jeffrey S Wefel; Ibrahima Gning; Alvina Acquaye; Elizabeth Vera-Bolanos; Mark R Gilbert; Charles S Cleeland; Tito Mendoza Journal: Cancer Date: 2012-03-13 Impact factor: 6.860
Authors: Sarah K Lageman; Jane H Cerhan; Dona E C Locke; S Keith Anderson; Wenting Wu; Paul D Brown Journal: J Neurooncol Date: 2009-07-19 Impact factor: 4.130
Authors: Kevin Duff; Joy D Humphreys Clark; Sid E O'Bryant; James W Mold; Randolph B Schiffer; Patricia B Sutker Journal: Arch Clin Neuropsychol Date: 2008-07-17 Impact factor: 2.813